We are live on ! Find out more
SBFM

Sunshine Biopharma
SBFM

8 hedge funds and large institutions have $89.6K invested in Sunshine Biopharma in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

20% less funds holding

Funds holding: 10 → 8 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

74% less capital invested

Capital invested by funds: $346K → $89.6K (-$257K)

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$183K
2
HF
HRT Financial
New York
+$107K
3
XT
XTX Topco
Cayman Islands
+$103K
4
Jane Street
Jane Street
New York
+$64.3K
5
SM
Sabby Management
Florida
+$47.7K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$279K
2
Citadel Advisors
Citadel Advisors
Florida
-$33.3K
3
BCM
Bridgeway Capital Management
Texas
-$17.3K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.22K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$32.1K +$183K +385 New
XT
2
XTX Topco
Cayman Islands
$18.4K +$103K +217 +7,233%
HF
3
HRT Financial
New York
$18K +$107K +224 +22,400%
Jane Street
4
Jane Street
New York
$11.6K +$64.3K +135 +3,375%
SM
5
Sabby Management
Florida
$8.35K +$47.7K +100 New
Qube Research & Technologies (QRT)
6
Qube Research & Technologies (QRT)
United Kingdom
$638 +$3.81K +8 New
Morgan Stanley
7
Morgan Stanley
New York
$418 +$2.38K +5 New
Bank of America
8
Bank of America
North Carolina
$42 – – –
National Bank of Canada
9
National Bank of Canada
Quebec, Canada
$26 – – –
MSG
10
Main Street Group
Virginia
$1 – – –
Renaissance Technologies
11
Renaissance Technologies
New York
– -$279K -231 Closed
Citadel Advisors
12
Citadel Advisors
Florida
– -$33.3K -28 Closed
BCM
13
Bridgeway Capital Management
Texas
– -$17.3K -14 Closed
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
– -$4K -3 Closed
Geode Capital Management
15
Geode Capital Management
Massachusetts
– -$1.22K -1 Closed
Two Sigma Investments
16
Two Sigma Investments
New York
– -$1.16K -1 Closed
FDCDDQ
17
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$5 – –
Osaic Holdings
18
Osaic Holdings
Arizona
– -$4 – –

SBFM Hedge Fund Activity: Q2 2024 in Review

8 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q2 2024, worth a combined $89.6K — down 74% from $346K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of SBFM and 4 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $183K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $279K sold.

  • 8 institutional investors held Sunshine Biopharma (SBFM) as of Q2 2024, down from 10 in Q1 2024.
  • Funds reported $89.6K of Sunshine Biopharma stock for Q2 2024, down 74% quarter-over-quarter.
  • 4 funds opened new Sunshine Biopharma positions in Q2 2024 and 6 closed out, a net change of -2 holders.
  • The largest Sunshine Biopharma buyer in Q2 2024 was Susquehanna International Group, an estimated $183K added.
  • The largest Sunshine Biopharma seller in Q2 2024 was Renaissance Technologies, an estimated $279K sold.

Based on aggregated 13F filings for Q2 2024.